News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
507,523 Results
Type
Article (51326)
Company Profile (58)
Press Release (456129)
Multimedia
Podcasts (83)
Webinars (13)
Section
Business (147768)
Career Advice (700)
Deals (19943)
Drug Delivery (112)
Drug Development (57579)
Employer Resources (67)
FDA (13463)
Job Trends (10073)
News (227392)
Policy (22599)
Tag
2025 Best Places to Work (9)
2026 Best Places to Work (13)
2027 BioCapital Standard (1)
2027 BioMidwest Standard (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Standard (2)
2027 Genetown Standard (1)
2027 Pharm Country Standard (3)
40 Under 40 (3)
Academia (2885)
Academic (1)
Accelerated approval (50)
ADA (37)
Adcomms (18)
Allergies (194)
Alliances (33649)
ALS (193)
Alzheimer's disease (1431)
Antibody-drug conjugate (ADC) (535)
Approvals (14279)
Artificial intelligence (615)
ASCO (257)
Autoimmune disease (359)
Automation (32)
Bankruptcy (163)
Belgium (29)
Best Places to Work (8008)
BIO (39)
Biologics (79)
Biomarkers (1)
BIOSECURE Act (20)
Biosimilars (176)
BioSpace Insights (102)
Biotechnology (37)
Bispecific (57)
Bladder cancer (210)
Brain cancer (79)
Breast cancer (710)
Cancer (5853)
Cardiovascular disease (465)
Career advice (657)
Career pathing (26)
CAR-T (268)
CDC (49)
CDMO (102)
Celiac Disease (8)
Cell-line development (1)
Cell therapy (712)
Cervical cancer (58)
Clinical research (52969)
Collaboration (1715)
Commercialization (60)
Company closure (3)
Compensation (442)
Complete response letters (51)
COVID-19 (2289)
CRISPR (78)
CRO (7)
C-suite (1378)
Cystic fibrosis (94)
Data (8566)
Decentralized trials (4)
Denatured (36)
Depression (161)
Dermatology (163)
Diabetes (596)
Diagnostics (4994)
Digital health (58)
Diversity (10)
Diversity, equity & inclusion (21)
Drug discovery (240)
Drug pricing (167)
Drug shortages (29)
Duchenne muscular dystrophy (207)
Earnings (47497)
Editorial (54)
Employer branding (8)
Employer resources (65)
ESMO (425)
Events (67563)
Executive appointments (1125)
Eye disease (17)
FDA (17547)
Fibrodysplasia Ossificans Progressiva (13)
Fragile X (4)
Friedreich's ataxia (12)
Frontotemporal dementia (24)
Funding (1496)
Gene editing (166)
Generative AI (42)
Gene therapy (523)
GLP-1 (874)
Government (3865)
Grass and pollen (4)
Guidances (326)
Healthcare (14566)
Hematology (171)
HIV (86)
Huntington's disease (50)
Idiopathic pulmonary fibrosis (13)
IgA nephropathy (115)
Immunology and inflammation (159)
Immuno-oncology (116)
Indications (243)
Infectious disease (2565)
Inflammatory bowel disease (188)
Inflation Reduction Act (12)
Influenza (106)
Intellectual property (241)
Interviews (76)
IPO (8415)
IRA (43)
Job creations (2265)
Job search strategy (591)
JPM (34)
Kidney cancer (25)
Kidney disease (143)
Labor market (78)
Layoffs (286)
Leadership (18)
Legal (4496)
Licensing (95)
Liver cancer (92)
Longevity (26)
Lung cancer (901)
Lung diease (20)
Lymphoma (460)
Machine learning (41)
Management (23)
Manufacturing (773)
Marketing (26)
MASH (192)
Medical affairs (6)
Medical device (14128)
Medtech (14451)
Melanoma (131)
Mergers & acquisitions (12374)
Metabolic disorders (1419)
Middle East (2)
mRNA (181)
Multiple sclerosis (188)
Multispecific (1)
NASH (13)
Netherlands (26)
Neurodegenerative disease (361)
Neuropsychiatric disorders (82)
Neuroscience (2856)
Neurotech (2)
NextGen: Class of 2026 (4760)
Non-profit (3578)
Now hiring (59)
Obesity (593)
Opinion (171)
Ovarian cancer (246)
Pain (266)
Pancreatic cancer (323)
Parkinson's disease (310)
Partnered (26)
Patents (488)
Patient advocacy (7)
Patient recruitment (792)
Patient selection (90)
Peanut (67)
People (50118)
Peptides (29)
Pharmaceutical (14)
Pharmacy benefit managers (25)
Phase 1 (15826)
Phase 2 (23065)
Phase 3 (18185)
Pipeline (10508)
Policy (266)
Postmarket research (2045)
Preclinical (5913)
Press Release (60)
Prostate cancer (321)
Psychedelics (49)
Radioligand (2)
Radiopharmaceuticals (311)
Rare diseases (932)
Real estate (4042)
Recruiting (30)
Regenerative medicine (31)
Regulatory (19752)
Reports (36)
Research institute (2247)
Resumes & cover letters (67)
Rett syndrome (37)
RNA editing (17)
RSV (60)
Saudi Arabia (1)
Schizophrenia (174)
Series A (257)
Series B (162)
Series C (1)
Service/supplier (2)
Sickle cell disease (101)
Special edition (15)
Spinal muscular atrophy (130)
Sponsored (26)
Startups (2733)
Stem cells (5)
Stomach cancer (18)
Substance use disorders (18)
Supply chain (107)
Switzerland (18)
Tariffs (61)
Tax incentives (2)
The Weekly (47)
Vaccines (853)
Venture capital (91)
Weight loss (384)
Wet AMD (6)
Women's health (126)
Worklife (7)
Date
Last 7 days (430)
Last 30 days (2275)
Last 365 days (20161)
2026 (18600)
2025 (19648)
2024 (23354)
2023 (27066)
2022 (36610)
2021 (39367)
2020 (38357)
2019 (34110)
2018 (26117)
2017 (23125)
2016 (22716)
2015 (26548)
2014 (20415)
2013 (18428)
2012 (19391)
2011 (19638)
2010 (17717)
Location
Africa (553)
Alabama (48)
Alaska (4)
Arizona (332)
Arkansas (14)
Asia (38104)
Australia (5680)
California (10093)
Canada (3000)
China (1981)
Colorado (501)
Connecticut (480)
Delaware (393)
Europe (69430)
Florida (1586)
Georgia (397)
Hawaii (2)
Idaho (41)
Illinois (1055)
India (79)
Indiana (589)
Iowa (21)
Japan (647)
Kansas (117)
Kentucky (39)
Louisiana (51)
Maine (41)
Maryland (1333)
Massachusetts (6762)
Michigan (244)
Minnesota (703)
Mississippi (7)
Missouri (137)
Montana (24)
Nebraska (23)
Nevada (125)
New Hampshire (86)
New Jersey (3225)
New Mexico (18)
New York (2818)
North Carolina (1374)
North Dakota (7)
Northern California (5041)
Ohio (356)
Oklahoma (18)
Oregon (35)
Pennsylvania (2178)
Puerto Rico (22)
Rhode Island (57)
South America (754)
South Carolina (93)
Southern California (4233)
Tennessee (230)
Texas (1883)
United States (37534)
Utah (332)
Virginia (253)
Washington D.C. (61)
Washington State (761)
West Virginia (4)
Wisconsin (121)
Wyoming (3)
507,523 Results for "china medical university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
NRDL+ Releases 2026 Mid-Year China Access Outlook as China Fine-Tunes Innovation Access Under Tighter Constraints
Executive strategic briefing examines how China’s evolving health policy, coverage, and financing environment is reshaping decisions across the medical technology lifecycle tags: #ChinaMarketAccess #LifeSciencesStrategy #PricingAndReimbursement #ChinaHealthPolicy #CommercialHealthInsurance
September 17, 2026
·
1 min read
China
In China’s shadow, Pfizer CEO calls for AI savings to bolster Big Pharma
Speaking at the Jefferies conference in London, Pfizer CEO Albert Bourla warned of China’s rise and spoke to how companies like his can compete by leveraging AI-discovered savings.
November 18, 2026
·
1 min read
·
Annalee Armstrong
China
6 potential blockbusters that could pave China’s path to 2030 ambitions
In its latest five-year plan, China has set its sights on developing five drugs that could each rake in more than $1 billion globally by 2030. Experts say it’s well on its way, with two medications having already met that bar.
November 4, 2026
·
8 min read
·
Tristan Manalac
Immunology and inflammation
Gilead shops in IL-23, inking $1.3B upfront I&I deal with China’s PepStar
Gilead Sciences has picked up a new inflammatory disease program from China’s PepStar Therapeutics to pair with the Phase 2 inflammatory bowel disease asset emvistegrast.
October 23, 2026
·
1 min read
·
Annalee Armstrong
Earnings
Pfizer, fresh to China’s obesity market, looks to Viagra model to compete
Pfizer is calling upon lessons learned from one of the first drugs ever made available on the internet—Viagra—as it commercializes a new obesity drug in China.
November 3, 2026
·
3 min read
·
Annalee Armstrong
China
Without US action on China’s innovation blitz, biotech leaders see a Rust Belt future
Policy uncertainty is hampering the growth of U.S. biotech as China rises thanks to carefully planned investment in the industry, experts said during a
BioSpace
webinar.
November 11, 2026
·
5 min read
·
Annalee Armstrong
Podcast
Disc’s redemption, China’s rise, Veradermics’ validation, ESMO’s headliners
China cracks down on some biotechnology ownership transfers—but will the new policy impact licensing deals?; Disc Medicine’s Phase 3 data sweep redeems rejected rare disease therapy, teeing up another FDA run; and the ESMO conference gets underway in Madrid this week, with much-anticipated data from Merck, and Summit Therapeutics.
October 21, 2026
·
1 min read
·
Jef Akst
China
China’s licensing deals soar as US biotechs enjoy a bumper M&A year
China may be taking the majority of licensing deals this year but those transactions don’t tell the whole story, according to Locust Walk, which points to the spike in M&A among U.S. biotechs as leveling the playing field.
October 21, 2026
·
3 min read
·
Annalee Armstrong
CHINA
Webinar: The China question: Can US biotechs lead as investment heads east?
In this webinar, BioSpace will gathered experts to discuss China’s impact on the future of biotech and how both U.S. and Chinese companies can thrive—and maybe even collaborate.
October 15, 2026
·
1 min read
·
Annalee Armstrong
China
China has a clear shot to 2030 goals, though economic, cultural barriers remain
To grow into a biopharma juggernaut, China aims to become the leading source of innovative medicines on the global markets—a goal that experts say the country is on track to hit.
November 11, 2026
·
5 min read
·
Tristan Manalac
1 of 50,753
Next